Cours Tikun Olam-Cannbit Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Actions
TKUN
IL0010843675
Produits pharmaceutiques
CA 2022 | 49,3 184,96 44,88 | CA 2023 | 44,23 165,94 40,27 | Capitalisation | 25,49 M 95,64 M 23,21 M |
---|---|---|---|---|---|
Résultat net 2022 | -48 M -180 M -43,7 M | Résultat net 2023 | -88 M -330 M -80,12 M | VE / CA 2022 | 1 234 605 x |
Dette nette 2022 | 17,5 M 65,66 M 15,93 M | Dette nette 2023 | 13,42 M 50,34 M 12,22 M | VE / CA 2023 | 879 698 x |
PER 2022 |
-0,97
x | PER 2023 |
-0,22
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 66,73% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Daniel Spira
AUD | Comptroller/Controller/Auditor | 69 | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Revital Aviram
BRD | Director/Board Member | 66 | 15/02/15 |
Erez Navon
BRD | Director/Board Member | 50 | - |
Ifat Kariv
CEO | Chief Executive Officer | 50 | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,05% | 3,66 Md | |
+112,12% | 2 Md | |
+80,95% | 61,69 M |